Abbreviations {#nc005}
=============

ABPM

:   ambulatory blood pressure monitoring

BMI

:   body mass index

BP

:   blood pressure

d

:   diastolic

dBP

:   diastolic blood pressure

DM

:   diabetes mellitus

ENT

:   ear, nose and throat

HTN

:   hypertension

s

:   systolic

sBP

:   systolic blood pressure

Introduction {#s0005}
============

The term 'epistaxis' is Latin, derived from the Greek, epistazein (epi -- above, over; stazein -- to drip) [@b0005]. Epistaxis is a common symptom of diverse conditions which may present as mild recurrent bleeds or severe life threatening rhinological emergency and may pose a challenge to even a skilled otolaryngologist [@b0010]. Globally, the true incidence remains unknown, but it is estimated that 60% of the population will have at least one episode of epistaxis in their lifetime, and 6% of them will seek medical attention. A slight male preponderance with 55% male and 45% female has been reported. Epistaxis is rare in neonates but common among children and young adults, and peaks in the sixth decade giving a bi-modal age presentation [@b0015].

Hypertension is increasing in prevalence in Saudi Arabia, affecting more than one fourth of the adult Saudi population [@b0020]. It is still doubtful whether a connection exists between epistaxis and hypertension [@b0030]. The prevalence rates of hypertension among patients with epistaxis range from 17 to 67% [@b0030]. Whether there is an association or cause and effect relationship between epistaxis and hypertension is a subject of longstanding controversy [@b0035].

Twenty-four-hour ambulatory BP monitoring (ABPM) is more valuable for predicting prognosis than other measures, as it more accurately assesses the risk of cardiovascular disease than measurements of BP made during clinic or office visits, and also ABPM is closely related to damage of target organs [@b0040]. Twenty-four-hour ABPM enables the continuous observance of changes in BP during activities of daily life, measuring automatically at specific time intervals, and therefore allowing for more accurate BP measurements [@b0045]. Serious spontaneous epistaxis may also be the presenting sign of underlying true hypertension in 43% of patients with no history of hypertension. However, hypertension per se does not appear to be a significant causal factor and/or factor of severity in serious spontaneous epistaxis [@b0050].

Blood vessels in the nose run superficially through the easily-damaged mucosa and are therefore relatively unprotected [@b0055]. The arterial hypertension would determine structural alterations of the nasal vessels similar to those verified in the cerebral circulation and retinal examination [@b0060]. The etiologic role of hypertension in epistaxis is not certain. It is possible that hypertension causes arteriolosclerotic nasal vascular changes that predispose hypertensives to increased susceptibility to epistaxis [@b0035]. Fundus examination of hypertensive epistaxics has demonstrated high prevalence of hypertensive retinal arteriolosclerosis in patients with epistaxis, which is an index of arteriolosclerotic changes in other parts of the body [@b0065]. Similarly, an association between duration of hypertension and left ventricular hypertrophy and nasal artery enlargement determined by rhinoscopy has been described among hypertensives with history of epistaxis, indicating that long lasting hypertension might contribute to epistaxis [@b0140].

The aim of our study is to evaluate the relationship between epistaxis and hypertension, its recurrence and control.

Patients and methods {#s0010}
====================

This is a prospective observational study conducted in Olaya Medical Center (Riyadh) during the period from May 2013 to June 2014. The study protocol was approved by the center's ethics committee.

Patients older than 18 years presented to ear, nose and throat (ENT) clinic were enrolled in the study after a written consent to participate in the study. A total of 80 patients were divided into two groups. Group A consisted of 40 patients who presented with idiopathic epistaxis. Group B consisted of 40 patients who served as a control group. These had presented with other reasons such as ear pain, headache, and dizziness. Patients with history of trauma to nose, local pathology, systemic diseases, bleeding disorders, patients on aspirin, clopidogrel or anticoagulants, and children were excluded from the study. None of the patients was lost to follow-up.

Rhinoscopy {#s0015}
----------

Anterior rhinoscopy was done using a nasal speculum, light source, and a head mirror with simple inspection. For posterior rhinoscopy, a tongue depressor was placed on the center of the base of the tongue with one hand, and the base of the tongue was pressed downward. A small warmed mirror was then introduced into the space between the soft palate and posterior pharyngeal wall to inspect the choana, the posterior ends of the turbinates, the posterior margin of the septum, and the nasopharynx, together with its roof and the ostia of the Eustachian tubes. Nasal sinoscopy was done using 1.7 mm rigid endoscope (30°), light source, camera, and monitor to evaluate all cases, and to detect site, severity and management method of epistaxis. Most patients underwent anterior rhinoscopy and sinoscopy, whereas posterior rhinoscopy was used only in a limited number of patients.

Management of epistaxis in our patients included four methods: first aid (including anterior flexion of the head, control of blood pressure and fluid replacement if needed and nose pinching after packing with xylometazoline, provided the blood pressure is not high), nasal packing with Merocel, electrocautery, and nasal balloon.

BP measurement {#s0020}
--------------

The patient was rested, and then BP was measured by the authors using a mercuric manometer in supine position. The first measurement was taken at presentation before rhinoscopy; the two other readings were taken 20 min and one hour after epistaxis control; the first value was rejected and the final result was calculated as the mean of the second and the third value.

During the following week, ABPM was initiated on a 24-h basis by using an Oscar 2, SunTech Medical, Inc. USA apparatus. The diagnosis of hypertension was made on the basis of BP ⩾ 140 mmHg systolic and/or ⩾ 90 mmHg diastolic or use of antihypertensive medications. Hypertension by 24-h ambulatory BP was defined when the mean daytime systolic BP was equal to or greater than 135 mmHg or when the mean daytime diastolic BP was equal to or greater than 85 mmHg, according to the report of seventh report of the 2003 US Hypertension Joint National Committee, European Society of Hypertension and European Society of Cardiology guidelines for hypertension [@b0145].

Patients were followed up for a period of three months for recurrent attacks of epistaxis and BP measurement in the same method as mentioned before. BP values after three months were used for statistical analysis as an indicator of BP control.

Statistical analysis {#s0025}
--------------------

Data entry and analysis was performed using SPSS version 15 software. Continuous and categorical variables are presented as mean plus or minus standard deviation and percentages, respectively. Mean values between the two groups were compared using *t*-test. Comparison between groups was done by Chi-square test. Pearson's correlation coefficient was used to test correlation between variables. *F*-test (One-Way Anova) was used to compare between more than two groups. A *p* value ⩽0.05 was considered statistically significant.

Results {#s0030}
=======

We enrolled 80 patients in this study with mean ± SD age of 47.86 ± 16.01. There were 55 males (68.8%) and 25 females (31.2%), and the study included 29 diabetic patients (36.3%), 32 smokers (40%) and 23 hypertensive patients (28.8%). Patients were divided into two groups: epistaxis group with 40 patients, and control group with 40 patients.

[Table 1](#t0005){ref-type="table"} shows non-significant difference between the two groups regarding all parameters assessed including age, sex, diabetes, smoking, BMI, history of hypertension and its duration in years. [Table 2](#t0010){ref-type="table"} showed that readings of BP were similar between the two groups regarding BP at presentation, ABPM and BP at three months. BP at presentation was not significantly higher in patients with epistaxis than control group. Results of ABPM readings classified patients into stress-induced hypertension (initial high and normal ABPM), masked hypertension (initial normal and high ABPM), pre-existing hypertension, newly diagnosed hypertension and normal BP. There were no significant differences between patient and control groups regarding the final diagnosis of hypertension.

Management of epistaxis in our patients included four methods, starting with first aid [@b0145], then nasal packing with Merocel [@b0060], electrocautery [@b0035], and nasal balloon [@b0030].

[Table 3](#t0015){ref-type="table"} shows non-significant differences between the various ways of epistaxis management regarding age, sex, diabetes, smoking, and hypertension history. There was a significantly higher number of attacks in patients managed by more complex interventions such as pack, electrocautery and balloon than those managed by first aid. [Table 4](#t0020){ref-type="table"} shows significantly higher BP readings in patients managed by more complex interventions such as pack, electrocautery and balloon than those managed by first aid, except for diastolic BP at presentation.

Discussion {#s0035}
==========

Association between epistaxis and hypertension is controversial [@b0080]. Our study was designed to provide an answer as to whether epistaxis may be a symptom related to the underlying presence of arterial hypertension, and to assess the effect of blood pressure control on epistaxis management.

This study included 80 patients who were divided into two groups; an epistaxis group and a control group. Both groups were well matched for gender, age, smoking habits, BMI and DM. The BP at presentation in both groups was in the high normal range, and initial hypertension was found in 14 patients with epistaxis (35%) and in 16 control patients (40%). Increased blood pressure at presentation may be due to patients' apprehension at the sight of blood [@b0085]. Kikidis et al. [@b0090] concluded that the presence of high arterial blood pressure during the actual episode of nasal bleeding cannot establish a causative relationship with epistaxis due to confounding stress and possible white coat phenomenon, but may lead to initial diagnosis of an already installed arterial hypertension.

In patients with epistaxis, the final diagnosis of hypertension was made in 18 patients (45%), with eight of them unaware of this diagnosis. Two patients who presented with high BP eventually had normal BP, whereas in the control group, 17 patients (42.5%) were found to have hypertension, with four of them unaware of the disease. Another two patients with initial high BP were found not to have hypertension. There was no significant difference between the two groups. These findings indicate no connection between epistaxis and hypertension.

The prevalence of hypertension in patients with epistaxis reportedly ranges from 24% to 64% [@b0095]. Theodosis et al. [@b0025] found that the final diagnosis of hypertension was set in 42.9% of patients admitted with epistaxis and in 28.9% of controls, which was not a statistically significant difference. Also, Nash and Field [@b0055] found that history of hypertension was noted in 43.7% of patients, of whom 40.5% were receiving antihypertensive medications. Similarly, Page et al. [@b0050] found that 55% of patients with epistaxis had a history of hypertension versus 48% for Viducich et al. [@b0100] and 47% for Pollice and Yoder [@b0105].

Our study showed that, in patients with epistaxis, the final there was no significant difference between male and female patients regarding BP readings. Further, the number of attacks over three months showed no significant correlation with age, sex, BMI, or smoking. The number of attacks was significantly higher in hypertensive patients; and in addition, there was a highly significant positive correlation between the number of attacks and BP readings including BP at presentation, ABPM and BP at three months. This indicates that uncontrolled hypertension is associated with more attacks of epistaxis and also that epistaxis may be difficult to control in patients with uncontrolled hypertension.

Systolic BP at presentation was significantly higher in patients who needed more complex interventions such as pack, balloon or cautery than patients managed by first aid. This indicates that hypertension renders the management of epistaxis more difficult. Diastolic pressure was not significantly different. Similar results were found for ABPM readings, except for diastolic BP over the 24 h.

Our results were in agreement with Theodosis et al. [@b0025] who found that patients admitted with epistaxis had elevated systolic pressures compared to controls, but no difference regarding the final diagnosis of hypertension, which indicates no connection between epistaxis and hypertension. Our results are also in agreement with Fuchs et al. [@b0110] who found that hypertension is not associated with history of epistaxis in the adulthood. Similar results were drawn by Karras et al. [@b0115] in a population of 1908 individuals. Lubianca Neto et al. [@b0140] found no definite association between blood pressure and history of adult epistaxis in hypertensive patients. Yüksel et al. [@b0120] found that the evidence available was insufficient to prove a significant association between hypertension and epistaxis. Lima and Knopfholz [@b0125] reported that epistaxis was unlikely to be a hypertensive emergency. Gifford and Orlandi [@b0130] found that the control of epistaxis may be more difficult in patients with hypertension.

Our results were in contrast with the results of Herkner et al. [@b0135] who found that patients with epistaxis have a higher blood pressure compared to that of control patients. Isezuo et al. [@b0035] also found an association between epistaxis and hypertension.

In conclusion, we found no definite association between epistaxis and hypertension. The initial high BP may be explained by confounding stress and white coat effect; however, we found no difference between the patients and control groups, and no difference regarding BP readings and the final diagnosis of hypertension. All these findings clearly show a non-association between epistaxis and hypertension.

We further concluded that the recurrence of epistaxis was higher in hypertensive patients, and higher BP made the management of epistaxis more complex, indicating that epistaxis was more difficult to control in hypertensive patients.

To the best of our knowledge, data assessing the correlation between blood pressure readings and management of epistaxis is scarce, and our study may be the first to address this correlation.

Our study limitations include a small number of patients and the short duration of follow-up. A larger study with more prolonged follow-up is needed to address the link between hypertension and epistaxis and whether a cause and effect relation exists.

Conclusion {#s0040}
==========

We demonstrated that there is no association between hypertension and epistaxis, and that epistaxis was not initiated by high BP. However, epistaxis was more difficult to control in hypertensive patients. Due to the limited number of patients and short duration of follow-up, larger studies are needed to fully address this problem.

Peer review under responsibility of King Saud University.

###### 

Clinical data of patients and control groups.

                                             Epistaxis group (40)   Control group (40)   *P* value
  -------------------------- --------------- ---------------------- -------------------- -----------
  Age                                        50.23 ± 16.62          45.5 ± 15.23         0.189
  Sex                        Male patients   27 (67.5%)             28 (70%)             0.809
  Female patients            13 (32.5%)      12 (30%)                                    
  DM                                         15 (37.5%)             14 (35%)             0.816
  Smoking                                    17 (42.5%)             15 (37.5%)           0.648
  History of HTN                             10 (25%)               13 (32.5%)           0.459
  Duration of HTN in years                   13.4 ± 7.63            10.38 ± 6.19         0.307
  BMI                                        29.56 ± 4.59           28.51 ± 4.98         0.331

DM = diabetes mellitus, HTN = hypertension, BMI = body mass index.

###### 

Blood pressure readings and final diagnosis of patients and control group.

                                   Epistaxis group (40)   Control group (40)   *P* value
  --------------------- ---------- ---------------------- -------------------- -----------
  sBP at presentation              138.13 ± 22.47         135.63 ± 19.91       0.6
  dBP at presentation              85.38 ± 9.57           83 ± 10.11           0.284
  ABPM s day                       146.57 ± 18.8          143.6 ± 17.59        0.467
  ABPM d day                       88.63 ± 9.31           86.58 ± 8.4          0.304
  ABPM s night                     137.53 ± 21.22         133.23 ± 20.21       0.356
  ABPM d night                     81.05 ± 12.6           79.15 ± 10.45        0.465
  ABPM s 24 Hours                  145.78 ± 19.33         142.35 ± 17.53       0.409
  ABPM d 24 Hours                  89.38 ± 12.07          86.3 ± 11.72         0.251
  sBP at 3 months                  128.75 ± 12.49         125 ± 10.06          0.143
  dBP at 3 months                  82 ± 7.32              80.63 ± 6.62         0.381
  Final diagnosis       Normal     20 (50%)               21 (52.5%)           0.782
  Stress HTN            2 (5%)     2 (5%)                                      
  Pre-existing HTN      10 (25%)   13 (32.5%)                                  
  Masked HTN            6 (15%)    3 (7.5%)                                    
  Newly diagnosed HTN   2 (5%)     1 (2.5%)                                    

sBP = systolic blood pressure, dBP = diastolic blood pressure, ABPM = ambulatory blood pressure monitoring, s = systolic, d = diastolic, HTN = hypertension.

###### 

Clinical data of patients group in relation to the way of management.

                                  First aid (15)   Pack (12)       Balloon (6)     Electrocautery (7)   *P* value
  ------------------- ----------- ---------------- --------------- --------------- -------------------- -----------
  Age                             52.27 ± 18.27    48.75 ± 17.97   45.67 ± 16.61   52.29 ± 12.38        0.842
  Sex                 Male        10 (66.7%)       8 (66.7%)       4 (66.7%)       5 (71.4%)            0.966
  Female              5 (33.3%)   4 (33.3%)        2 (33.3%)       2 (28.6%)                            
  Smoking                         7 (46.7%)        6 (50%)         3 (50%)         1 (14.3%)            0.423
  HTN history                     1 (6.7%)         4 (33.3%)       2 (33.3%)       3 (42.9%)            0.208
  BMI                             30.43 ± 4.57     31.5 ± 4.82     26.6 ± 2.53     26.89 ± 3.7          0.049
  DM                              7 (46.7%)        4 (33.3%)       2 (33.3%)       2 (28.6%)            0.823
  Number of attacks   0           10 (66.7%)       2 (16.7%)       1 (16.7%)       2 (28.6%)            0.041
  1                   3 (20%)     2 (16.7%)        0               1 (14.3%)                            
  2                   2 (13.3%)   5 (41.7%)        5 (83.3%)       3 (42.9%)                            
  3                   0           3 (25%)          0               1 (14.3%)                            

DM = diabetes mellitus, HTN = hypertension, BMI = body mass index.

###### 

Blood pressure readings of patients group in relation to the way of management.

                        First aid (15)   Pack (12)        Balloon (6)      Electrocautery (7)   *P* value
  --------------------- ---------------- ---------------- ---------------- -------------------- -----------
  sBP at presentation   126 ± 14.29      143.33 ± 21.57   156.67 ± 29.27   139.29 ± 21.68       0.021
  dBP at presentation   80.67 ± 7.04     87.92 ± 9.64     90.83 ± 11.58    86.43 ± 9.88         0.083
  ABPM s day            133.13 ± 6.59    160.42 ± 21.67   149.83 ± 16.83   148.86 ± 15.73       0.001
  ABPM d day            83 ± 5.3         92.08 ± 8.89     92 ± 11.63       91.86 ± 10.65        0.026
  ABPM s night          122.2 ± 9.25     153.75 ± 23.72   141.5 ± 18.01    135.38 ± 20.7        \<0.0001
  ABPM d night          72.67 ± 7.72     87.58 ± 11.55    85.33 ± 14.21    84.14 ± 13.79        0.007
  ABPM s 24 h           131.4 ± 7.37     159.92 ± 21.63   150 ± 16.31      148.74 ± 16.71       \<0.0001
  ABPM d 24 h           85.67 ± 13.54    90.58 ± 11.19    92 ± 11.56       93 ± 10.91           0.5
  sBP 3 months          120.67 ± 11      134.17 ± 13.11   135 ± 5.48       131.43 ± 11.07       0.01
  dBP 3 months          76.33 ± 6.67     85.83 ± 5.97     87.5 ± 2.74      82.86 ± 5.67         \<0.0001

sBP = systolic blood pressure, dBP = diastolic blood pressure, ABPM = ambulatory blood pressure monitoring, s = systolic, d = diastolic, HTN = hypertension.
